Empresa Orion Biotech Opportunities Corp. OTC Markets
Acciones
ORIAU
KYG6780C1252
Holding Companies
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Zuie Chin Huang
FOU | Founder | 58 | 05/02/21 |
Chrystyna Stecyk
FOU | Founder | 61 | 05/02/21 |
Mark Kayal
DFI | Director of Finance/CFO | 39 | - |
Director/Board Member | 51 | - | |
Samuel Broder
BRD | Director/Board Member | 79 | - |
Corporate Officer/Principal | - | - | |
John Phelan
PRN | Corporate Officer/Principal | 60 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Zuie Chin Huang
FOU | Founder | 58 | 05/02/21 |
Samuel Broder
BRD | Director/Board Member | 79 | - |
James Collins
BRD | Director/Board Member | 58 | - |
Director/Board Member | 51 | - | |
Louisa Rodriguez
BRD | Director/Board Member | 64 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 5 000 000 | 0 | 0 | 74,00 % |
Acción B | 1 | 20 000 000 | 18 500 000 ( 92,50 %) | 0 |
Información de la empresa
Orion Biotech Opportunities Corp.
One Vanderbilt Avenue 26th floor
10017, New York
+
http://www.orionbiotechopportunities.comVaria. 1 de ene. | Capi. | |
---|---|---|
+191,37 % | 6970,36 M | |
+5,09 % | 1044,38 M | |
+2,10 % | 982 M | |
+41,91 % | 872 M | |
+24,45 % | 814 M | |
+11,31 % | 675 M | |
+1,72 % | 664 M | |
-.--% | 600 M | |
+3,61 % | 503 M |